[1]曲瑞泽 综述 周鑫 付卫**审校.家族性腺瘤性息肉病伴发腹腔硬纤维瘤的诊断和治疗进展[J].中国微创外科杂志,2021,01(2):150-154.
点击复制

家族性腺瘤性息肉病伴发腹腔硬纤维瘤的诊断和治疗进展()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2021年2期
页码:
150-154
栏目:
文献综述
出版日期:
2021-02-25

文章信息/Info

作者:
曲瑞泽 综述 周鑫 付卫**审校
（北京大学第三医院普外科，北京100191）
文献标志码:
A

参考文献/References:

[1]Nishisho I,Nakamura Y,Miyoshi Y,et al.Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.Science,1991,253(5020):665-669.
[2]Shiroky JS,LernerEllis JP,Govindarajan A,et al.Characteristics of adrenal masses in pamilial adenomatous polyposis.Dis Colon Rectum,2018,61(6):679-685.
[3]Haddad FG,El Bitar S,Deeb L.Growing in silence!Gastroenterology,2017,153(5):1203-1204.
[4]Devata S,Chugh R.Desmoid tumors:a comprehensive review of the evolving biology,unpredictable behavior,and myriad of management options.Hematol Oncol Clin North Am,2013,27(5):989-1005.
[5]Koskenvuo L,Ristimaki A,Lepisto A.Comparison of sporadic and FAPassociated desmoidtype fibromatoses.J Surg Oncol,2017,116(6):716-721.
[6]Kummar S,O’Sullivan Coyne G,Do KT,et al.Clinical activity of the γsecretase inhibitor PF03084014 in adults with desmoid tumors (aggressive fibromatosis).J Clin Oncol,2017,35(14):1561-1569.
[7]Calogero A,Sagnelli C,Carlomagno N,et al.Familial polyposis coli:the management of desmoid tumor bleeding.Open Med (Wars),2019,14:572-576.
[8]Septer S,Lawson CE,Anant S,et al.Familial adenomatous polyposis in pediatrics: natural history,emerging surveillance and management protocols,chemopreventive strategies,and areas of ongoing debate.Fam Cancer,2016,15(3):477-485.
[9]Speake D,Evans DG,Lalloo F,et al.Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations.Br J Surg,2007,94(8):1009-1013.
[10]Bülow S.Results of national registration of familial adenomatous polyposis.Gut,2003,52(5):742-746.
[11]Church J,Lynch C,Neary P,et al.A desmoid tumorstaging system separates patients with intraabdominal,familial adenomatous polyposisassociated desmoid disease by behavior and prognosis.Dis Colon Rectum,2008,51(6):897-901.
[12]Church J,Xhaja X,LaGuardia L,et al.Desmoids and genotype in familial adenomatous polyposis.Dis Colon Rectum,2015,58(4):444-448.
[13]Kallenberg FGJ,Latchford A,Lips NC,et al.Duodenal adenomas in oatients with multiple colorectal adenomas without germline APC or MUTYH mutations.Dis Colon Rectum,2018,61(1):58-66.
[14]Wang J,Jia N,Lin Q,et al.Clinicopathological and molecular characteristics of abdominal desmoid tumors in the Chinese population:a singlecenter report of 15 cases.Oncol Lett,2019,18(6):6443-6450.
[15]Trautmann M,Rehkmper J,Gevensleben H,et al.Novel pathogenic alterations in pediatric and adult desmoidtype fibromatosis:a systematic analysis of 204 cases.Sci Rep,2020,10(1):3368.
[16]Vitellaro M,Piozzi G,Signoroni S,et al.Shortterm and longterm outcomes after preventive surgery in adolescent patients with familial adenomatous polyposis.Pediatr Blood Cancer,2020,67(3):e28110.
[17]Clark SK,Smith TG,Katz DE,et al.Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis.Br J Surg,1998,85(7):970-973.
[18]Quast DR,Schneider R,Burdzik E,et al.Longterm outcome of sporadic and FAPassociated desmoid tumors treated with highdose selective estrogen receptor modulators and sulindac:a singlecenter longterm observational study in 134 patients.Fam Cancer,2016,15(1):31-40.
[19]Woltsche N,Gilg MM,Fraissler L,et al.Is wide resection obsolete for desmoid tumors in children and adolescents?Evaluation of histological margins,immunohistochemical markers,and review of literature.Pediatr Hematol Oncol,2015,32(1):60-69.
[20]Miyoshi Y,Ando H,Nagase H,et al.Germline mutations of the APC gene in 53 familial adenomatous polyposis patients.Proc Natl Acad Sci U S A,1992,89(10):4452-4456.
[21]Casillas J,Sais GJ,Greve JL,et al.Imaging of intra and extraabdominal desmoid tumors.Radiographics,1991,11(6):959-968.
[22]Nakanishi K,Shida D,Tsukamoto S,et al.Multiple rapidly growing desmoid tumors that were difficult to distinguish from recurrence of rectal cancer.World J Surg Oncol,2017,15(1):180.
[23]Fisher C,Thway K.Aggressive fibromatosis.Pathology,2014,46(2):135-140.
[24]van Houdt WJ,Wei IH,Kuk D,et al.Yield of colonoscopy in identification of newly diagnosed desmoidtype fibromatosis with underlying familial adenomatous polyposis.Ann Surg Oncol,2019,26(3):765-771.
[25]Nieuwenhuis MH,MathusVliegen EM,Baeten CG,et al.Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients.Br J Cancer,2011,104(1):37-42.
[26]Desurmont T,Lefèvre JH,Shields C,et al.Desmoid tumour in familial adenomatous polyposis patients: responses to treatments.Fam Cancer,2015,14(1):31-39.
[27]Soravia C,Berk T,McLeod RS,et al.Desmoid disease in patients with familial adenomatous polyposis.Dis Colon Rectum,2000,43(3):363-369.
[28]Peng PD,Hyder O,Mavros MN,et al.Management and recurrence patterns of desmoids tumors:a multiinstitutional analysis of 211 patients.Ann Surg Oncol,2012,19(13):4036-4042.
[29]Leithner A,Gapp M,Leithner K,et al.Margins in extraabdominal desmoid tumors:a comparative analysis.J Surg Oncol,2004,86(3):152-156.
[30]DE Marchis ML,Tonelli F,Quaresmini D,et al.Desmoid tumors in familial adenomatous polyposis.Anticancer Res,2017,37(7):3357-3366.
[31]Mehrotra AK,Sheikh S,Aaron AD,et al.Fibromatoses of the extremities:clinicopathologic study of 36 cases.J Surg Oncol,2000,74(4):291-296.
[32]Eastley N,Aujla R,Silk R,et al.Extraabdominal desmoid fibromatosis:a sarcoma unit review of practice,long term recurrence rates and survival.Eur J Surg Oncol,2014,40(9):1125-1130.
[33]Seidensaal K,Harrabi SB,Weykamp F,et al.Radiotherapy in the treatment of aggressive fibromatosis:experience from a single institution.Radiat Oncol,2020,15(1):143.
[34]Zelefsky MJ,Harrison LB,Shiu MH,et al.Combined surgical resection and iridium 192 implantation for locally advanced and recurrent desmoid tumors.Cancer,1991,67(2):380-384.
[35]Shin SH,Ko KR,Cho SK,et al.Surgical outcome of desmoid tumors: adjuvant radiotherapy delayed the recurrence,but did not affect longterm outcomes.J Surg Oncol,2013,108(1):28-33.
[36]Chouliaras K,Senehi R,Ethun CG,et al.Role of radiation therapy for retroperitoneal sarcomas:an eightinstitution study from the US Sarcoma Collaborative.J Surg Oncol,2019,120(7):1227-1234.
[37]Najafi A,Fuchs B,Binkert CA.Midterm results of MRguided highintensity focused ultrasound treatment for relapsing superficial desmoids.Int J Hyperthermia,2019,36(1):538-542.
[38]Signoroni S,Frattini M,Negri T,et al.Cyclooxygenase2 and plateletderived growth factor receptors as potential targets in treating aggressive fibromatosis.Clin Cancer Res,2007,13(17):5034-5040.
[39]Ioannidis O,Paraskevas G,Chatzopoulos S,et al.Multiple desmoid tumors in a patient with familial adenomatous polyposis caused by the novel W421X mutation.Rev Esp Enferm Dig,2012,104(3):146-150.
[40]Hansmann A,Adolph C,Vogel T,et al.Highdose tamoxifen and sulindac as firstline treatment for desmoid tumors.Cancer,2004,100(3):612-620.
[41]Moore RA,Derry S,Aldington D,et al.Single dose oral analgesics for acute postoperative pain in adults:an overview of Cochrane reviews.Cochrane Database Syst Rev,2015,2015(9):CD008659.
[42]Francis WP,Zippel D,Mack LA,et al.Desmoids:a revelation in biology and treatment.Ann Surg Oncol,2009,16(6):1650-1654.
[43]Benech N,Walter T,Saurin JC.Desmoid tumors and celecoxib with sorafenib.N Engl J Med,2017,376(26):2595-2597.
[44]Sakai T,Nishida Y,Hamada S,et al.Immunohistochemical staining with nonphospho βcatenin as a diagnostic and prognostic tool of COX2 inhibitor therapy for patients with extraperitoneal desmoidtype fibromatosis.Diagn Pathol,2017,12(1):66.
[45]Mastoraki A,Schizas D,Vergadis C,et al.Recurrent aggressive mesenteric desmoid tumor successfully treated with sorafenib:a case report and literature review.World J Clin Oncol,2019,10(4):183-191.
[46]Kim JH,Ryu MH,Park YS,et al.Intraabdominal desmoid tumors mimicking gastrointestinal stromal tumors 8 cases:a case report. World J Gastroenterol,2019,25(16):2010-2018.
[47]Santti K,Beule A,Ronty M,et al.The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor.A case report.Acta Oncol,2019,58(6):897-900.
[48]Desurmont T,Lefevre JH,Shields C,et al.Desmoid tumour in familial adenomatous polyposis patients: responses to treatments.Fam Cancer,2015,14(1):31-39.
[49]Lindor NM,Dozois R,Nelson H,et al.Desmoid tumors in familial adenomatous polyposis:a pilot project evaluating efficacy of treatment with pirfenidone.Am J Gastroenterol,2003,98(8):1868-1874.
[50]Wang YC,Wong JU.Complete remission of pancreatic head desmoid tumor treated by COX2 inhibitor:a case report.World J Surg Oncol,2016,14(1):190.

备注/Memo

备注/Memo:
基金项目：国家自然科学基金重大研究计划（91959110）**通讯作者，Email：fuwei@bjmu.edu.cn
更新日期/Last Update: 2021-05-11